The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder? - Nantes Université Access content directly
Journal Articles Neuropsychiatry Year : 2017

The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?

Abstract

Now more than ever, let us continue to develop personalized medicine to improve the remission rate for treatment resistant depressed patients. Recent findings about psychomotor retardation-a core symptom of depression-provide new insights into the predictive efficiency of personalized treatments, such as rTMS.
Fichier principal
Vignette du fichier
Deschamps et al (2017)_The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder.pdf (112.06 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03340120 , version 1 (10-09-2021)

Identifiers

Cite

Thibault Deschamps, Anne Sauvaget, Samuel Bulteau, Véronique Thomas-Ollivier. The Psychomotor Retardation, a Marker of Response to rTMS Treatment in Patients with Major Depressive Disorder?. Neuropsychiatry, 2017, 07, ⟨10.4172/neuropsychiatry.1000274⟩. ⟨hal-03340120⟩
45 View
62 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More